학술논문
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Document Type
Letter
Author
Campanella, A.; Capasso, A.; Taccetti, C.; Scarfò, L.; Ghia, P.; Heltai, S.; Albi, E.; Ranghetti, P.; Perotta, E.; Martini, F.; Sant'Antonio, E.; Colia, M.; Combi, C.; Scarano, E.; Frenquelli, M.; Herishanu, Y.; Levi, S.; Haggenburg, S.; Kater, A.P.; Hazenberg, M.; Nijhof, I.S.; Hofsink, Q.; Chatzikonstantinou, T.; Demosthenous, C.; Karypidou, M.; Stamatopoulos, K.; Doubek, M.; Kotaskova, J.; Kättström, M.; Giannopoulos, K.; Zaleska, J.; Simkovic, M.; Vrbacky, F.; Moreno, C.; Raya, A.M.; Massaia, M.; Bisogno, D.; Tripoli, I.E.; Bumbea, H.; Alshemmari, S.; Stavroyianni, N.; Popov, V.M.; Roman, V.; Locatelli, M.
Source
In: American Journal of Hematology . (American Journal of Hematology, April 2024, 99(4):745-750)
Subject
Language
English
ISSN
10968652
03618609
03618609